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Introduction Biodegradable porous scaffolds are found to be very promising bone substitutes, acting 
as a temporary physical support to guide new tissue regeneration, until the entire scaffold is totally 
degraded and replaced by the new tissue.
Objective The aim of this study was to investigate cytotoxicity of a synthesized calcium hydroxyapatite-
based scaffold, named ALBO-OS, with high porosity and optimal topology.
Methods The ALBO-OS scaffold was synthesized by the method of polymer foam template. The analysis 
of pore geometry and scaffold walls’ topography was made by scanning electron microscope (SEM). The 
biological investigations assumed the examinations of ALBO-OS cytotoxicity to mouse L929 fibroblasts, 
using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromidefor (MTT) and lactate dehydrogenase 
(LDH) tests and inverse phase microscopy.
Results The SEM analysis showed high porosity with fair pore distribution and interesting morphology 
from the biological standpoint. The biological investigations showed that the material is not cytotoxic 
to L929 cells. Comparison of ALBO-OS with Bio-Oss, as the global gold standard as a bone substitute, 
showed similar results in MTT test, while LDH test showed significantly higher rate of cell multiplication 
with ALBO-OS.
Conclusion The scaffold design from the aspect of pore size, distribution, and topology seems to be very 
convenient for cell adhesion and occupation, which makes it a promising material as a bone substitute. 
The results of biological assays proved that ALBO-OS is not cytotoxic for L929 fibroblasts. In comparison 
with Bio-Oss, similar or even better results were obtained.
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INTRODUCTION
Bone is a dynamic and highly vascularized tis-
sue which has significant self-healing capacity 
for the repair of small fractures. However, bone 
grafts are needed to provide support, fill bone 
defect, and enhance biological repair in larger 
ones. Due to source limitation of autogenic 
bone grafts and immunologic rejection prob-
lem of natural bone grafts, bone tissue engi-
neering technique has become a crucial strat-
egy for permanent repair of bone defects in 
current tissue transplantation methodologies 
and grafting [1, 2, 3].
Hence, 3D biodegradable porous struc-
tures well-known as scaffolds are found to 
be a promising solution because they act as a 
temporary physical support to guide new tissue 
regeneration until the entire scaffold is totally 
degraded and replaced by the new tissue. Ide-
ally, these temporary scaffolds should be po-
rous in order to accommodate cell growth and 
facilitate both tissue regeneration and vascu-
larization [4, 5, 6]. Furthermore, they should 
also be biocompatible, mechanically strong, 
and have a biodegradation rate similar to the 
cell/tissue growth rates. Three more properties 
should be fulfilled: (i) the material should es-
tablish a stable direct connection with patient’s 
bone, both structural and functional, (ii) the 
material should be osteoinductive, and (iii) it 
should be osteoconductive, for recruitment of 
mesenchymal progenitor cells and guided bone 
deposition on the scaffolds surface.
Scaffold has to favor cell attachment, prolif-
eration and differentiation, bone growth, and 
in vivo revascularization. It should also possess 
mechanical properties matching those of target 
tissue, designed geometrically and functionally 
to mimic native extracellular matrix environ-
ment as much as possible [7–10]. A ceramic 
carrier designed to mimic bone structure hi-
erarchy covered by polymer thin films with 
appropriate properties is probably one of the 
best solutions for the above requested scaffold 
construction.
ALBO-OS scaffold was developed as inno-
vative product following the aforementioned 
requirements. It is a composite of calcium 
hydroxyapatite (CHA) and poly-lactide-co-
glycolide (PLGA) with very high porosity and 
pronounced topography of the inner walls. 
PLGA (coating CHA in ALBO-OS) belongs 
to the family of synthetic biodegradable poly-
esters commonly used in tissue engineering, 
as it satisfies the requirements of mechanical 
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properties and convenient processing [11, 12]. It has fa-
vorable degradation rate that matches the rate of healing 
of damaged bone tissue [13]. This composite was made in 
an attempt to enhance the scaffold surface for various cell 
activities, including cell adhesion, proliferation and release 
of cytoplasmic metabolites, changes of the cell shape, den-
sity of their occupations, etc.
Presented in vitro study was aimed at investigating the 
biological response (cytotoxicity and cell adhesion) of fi-
bre-like cells to ALBO-OS. The potential of such scaffold 
was compared with Bio-Oss through 3-(4,5-Dimethylth-
iazol-2-yl)-2,5-diphenyltetrazolium bromidefor (MTT) 
and lactate dehydrogenase (LDH) tests; cell line of mouse 
fibroblasts L929 was used for investigation of biological 
response to the implanted material.
OBJECTIVE
The aim of this study was to investigate cytotoxicity of the 
synthesized scaffold on the base of calcium hydroxyapatite 
and poly(lactic-co-glycolic acid) (PLGA), with improved 
structural design, on the cell line of mouse fibroblasts L929 
using MTT and LDH assays and inverse phase microscopy.
METHODS
Scaffold preparation
The synthesis of scaffold named ALBO-OS consisted of 
three stages: synthesis of CHA powder, production of CHA 
granules, and deposition of a thin film of PLGA on the 
surface of the granules.
CHA powder was synthesized hydrothermally from 
approximately stoichiometric mixture of (NH4)2HPO4 
and Ca(OH)2, by procedure given in our previous inves-
tigations [14, 15]. The procedure, in brief, consisted of 
the following: 500 ml of a 2.32 cmol aqueous solution 
of (NH4)2HPO4 was poured into 500 ml of a 3.02 cmol 
aqueous solution of Ca(OH)2, under vigorous stirring. 
The mixture’s pH value was adjusted to 7.4, and it was 
autoclaved at 150°C under a pressure of 5×105 Pa for 8 
h. After the hydrothermal treatment, the precipitate was 
decanted, dried at 80°C for 48 h, washed with deionized 
water, and ultracentrifuged. In the next step, a mixture 
of 5 g of hydrothermally synthesized CHA and 1.5 g of 
poly(ethylenevinyl acetate)/poly(ethylene vinyl versatate) 
(PEVA/PEVV) was made and further processed in the 
autoclave at 120°C for 2 h. The obtained CHA powder 
was further used for production of CHA granules.
The CHA powder was mixed with water to form ce-
ramic slurry. To enhance the wetness of the slurry and 
its rheological properties, 2% of PVA was added. Poly-
urethane (PU) foam with adequate pore size distribution 
was then dipped into the slurry followed by gently squeez-
ing the foam several times to allow the slurry to penetrate 
the foam and the excess slurry to be squeezed out. Com-
pressed air through an air gun was used to avoid a block-
age of pores. The ceramic slurry-coated PU foam was left 
to dry at room temperature and was then heated in an 
oven at 600°C to burn out the PU foam, and then sintered 
at 1,200°C for 4 h. The obtained porous CHA compact was 
further disintegrated into granules of suitable size.
The final step in ALBO-OS synthesis was the deposi-
tion of PLGA thin film on the surface of CHA granules. 
PLGA pellets (50:50, M = 45,000–70,000; Durect Corpora-
tion, Cupertino, CA, USA) were dissolved in chloroform 
to obtain 1% w/w solution which was further poured over 
CHA granules. After the solvent evaporation, thin PLGA 
film was formed at the granules’ surface [16].
Scaffold characterization
For structural analysis of CHA granules, as the main compo-
nent of ALBO-OS, the methods of X-ray diffraction (XRD) 
and Fourier transform infrared spectroscopy (FTIR) were 
used. For XRD analysis, Philips PW 1050 diffractometer 
(Koninklijke Philips N. V., Amsterdam, the Netherlands) 
with Cu-Kα1-2 lamp was used, and the data were collected 
in the 2 θ range from 9° to 67°, in steps of 0.055°, and with 
exposure time of 2 seconds per step. For FTIR analysis, 
spectrometer 380 Nicollet FTIR (Thermo Electron Corpo-
ration, Waltham, MA, USA) was used. FTIR spectra were 
taken in the spectral range 4,000–400 cm-1.
Scanning electron microscopy (SEM) was used to ana-
lyze the microstructure of pore walls of CHA granules. 
Sample preparation for SEM was performed by steaming 
with gold in BALZERS, and the samples were observed 
under a JSM-5300 microscope (JEOL USA, Inc., Peabody, 
MA, USA).
Total porosity of the synthesized CHA scaffolds was 
determined by using the following equations: bulk den-
sity (ρB) = weight of the sample divided by volume of the 
sample; theoretical density of the CHA (ρ0) = 3.16 g/cm2; 
relative density (R.D.) = (ρB/ρ0) × 100%; and total poros-
ity = 100% - R.D. The dimensions and the weight of each 
sample were measured and recorded using the weight of 
displaced liquid (water) with measured quantity of the 
sample. Three identical specimens were used to determine 
the total porosity.
Nano-porosity of the CHA scaffold was estimated by 
high-pressure mercury intrusion porosimeter (Carlo Erba 
Porosimeter 2000 with Milestone 100 Software System). The 
porosimeter operates in the pressure interval 0.1–200 MPa, 
enabling estimation of pores in interval 7.5–15,000 nm.
Biological examination
Biological samples
Study included three different materials (ALBO-OS, Bio-
Oss, and control) and three independent experiments 
(three biological replicates). In each experiment, five wells 
were analyzed for each material, which makes 15 samples 






The mouse fibroblasts L929 were grown in appropriate 
containers, in a culture medium (DMEM) with addition of 
10% fetal calf serum (FCS), L-glutamine (3 mM), penicil-
lin (100 IU/ml) and streptomycin (100 mg/ml). After sup-
plementation, pH of the medium solution was adjusted to 
7.2 using a bicarbonate buffer. Thereafter, the solution was 
filtered through a filter with a pore size of 0.22 μm. Cells 
were grown at the temperature of 37°C in air with 5% CO2.
To optimize the growing conditions of cells, experimen-
tal curves of cell growth were defined, depending on the 
growth time. The cells were monitored using alamarBlue 
(Thermo Fisher Scientific, Waltham, MA, USA) assay (at 
570 nm) after two, 24, 48, 72, and 96 hours. The growth 
curves after seeding 500, 1,000, 2,000, 4,000, and 8,000 cells 
were investigated. Based on the growth curves, the time re-
quired to double the cell number was determined and on 
its basis the optimal number of cells for experiments was 
determined. That number was 6,000 cells/well in the 96-well 
plate, for indirect toxicity testing, and 100,000 cells/well in 
the six-well plate for direct toxicity testing [17, 18, 19].
MTT test
For the test of indirect cytotoxicity (MTT test) the extracts 
were obtained by suspending the granules of ALBO-OS in 
culture medium (DMEM with10% FCS) at a concentration 
of 0.02 g/ml and incubated at 37°C for one, 24, or 72 hours 
with constant agitation. After incubation, extract solutions 
were centrifuged for 10 minutes at 2,000 rpm, decanted 
and filtered through a 0.22 μm filter (to eliminate any solid 
particles of the material). pH values of the obtained solu-
tions were determined and they were used for MTT test.
For MTT test, L929 cells were seeded in 96-well cell 
culture plates in 100 μl growth medium at concentration 
of 6,000 cells/well. After 24 h of culture in a humidified 
atmosphere with 5% CO2 at 37.1°C, medium was removed 
and replaced with 100 μl of previously prepared extract 
dilutions (obtained after one-, 24-, or 72-hour contact of 
medium and ALBO-OS). Extract of Geistlich BioOss (as a 
global gold standard) obtained only after 72-hour contact 
of BioOss with culture medium was used for comparison 
of cell viability on these two materials. Cells cultured in 
growth medium served as controls. After 72 h of incuba-
tion with each extract, the cell culture was treated with 20 
μl/well of MTT (5 mg/ml in PBS) and incubated for fur-
ther 4 h in humidified atmosphere with 5% CO2 at 37.1°C. 
Then, MTT was removed and 100 μl 10% SDS in 0.01 M 
HCl was added in order to dissolve the formazan crystals. 
The next day, the optical density (OD) was read on ELISA 
multiwell microplate reader at 570 nm [17, 18, 19].
LDH test
To determine direct cytotoxicity, a thin (300 μm – 1 mm) 
ALBO-OS coating of the granules was deposited on round 
polypropylene flakes, which were further fixed to 6-well 
plates and sterilized with γ-rays (25 kGy, 48 h). BioOss 
granules prepared in the same way were used for com-
parison with ALBO-OS. Then, the optimal number of 
L929 cells (100,000 per well) was added. Further, plates 
were incubated for one, two and seven days in humidified 
atmosphere with 5% CO2 at 37.1°C. The number of vi-
able cells was estimated after physical lysis. The cells were 
lysed by alternate freezing and defrosting in three cycles, 
then centrifuged and LDH level was determined from the 
obtained supernatant. Supernatant aliquots of each well 
were transferred to a new 96-well plate and the LDH quan-
tified using an enzymatic kit (Sigma Aldrich, St. Louis, 
MO, USA). Number of cells was determined by the level of 
LDH using previously constructed calibration curve. The 
optical density was read on microplate reader at 490 nM.
Statistical analysis
The results are presented as mean ± standard deviation 
(SD). The differences between groups (independent sam-
ples) were analyzed using One-way Analysis of Variance 
(ANOVA) and Student’s t-test. Statistical analysis was per-
formed using SPSS statistical software version 15.0 (SPSS, 
Chicago, Illinois). All p-values less than 0.05 were consid-
ered to be significant.
Phase contrast microscopy
Cells were observed under phase contrast microscope 
(Leica Microsystems, Wetzlar, Germany) after contact 
with the extracts of ALBO-OS for 24, 48, and 72 h. Their 
morphology and the difference in cell density compared 
to controls (cells cultivated in culture medium, for 24, 48, 
and 72 h also) were evaluated [17, 18, 19]. The percentage 
of survived cells in ALBO-OS extracts was obtained by 
analysis of contrast phase microscopy images for each well 
in each experiment (15 images). The results are presented 




The obtained XRD spectrum (Graph 1) showed that the 
phase composition of CHA scaffold granules corresponds 
to carbonate calcium hydroxyapatite Ca10(PO4)6(OH)2 
(JCPDS 9–432). All characteristic diffraction peaks were 
present: (002) at 2θ = 25.98°, (120) at 2θ = 29.03°, (121) 
at 2θ = 31.87°, (300) at 2θ = 33.07°, (310) at 2θ = 39.94°, 
(222) at 2θ = 46.82° and (123) at 2θ = 49.54°.
FTIR spectrum of CHA granules (Graph 2) showed the 
bands characteristic for CHA. The bands around 1,092, 
1,046, 603, and 568 cm-1 correspond to PO43- group. Vibra-
tions of OH-groups were detected at about 632 cm-1. Vi-
Sjerobabin N. et al. Cytotoxicity investigation of a new hydroxyapatite scaff old with improved structural design
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brations of CO32− group at 1,449 and 870 cm-1 indicate the 
presence of carbonate groups in the apatite structure that 
partially replace OH-ions. Based on this, it was identified 
that the carbonate apatite type B had been obtained, which 
is the most active form of carbonated apatite (type B pre-
dominates in the bones of young people, while the A type 
predominates in the bones of elderly people). The bands 
at 2,921 cm-1 and 3,024 cm-1 correspond to the ν(C-H) 
symmetric and asymmetric (respectively) stretching vibra-
tions of intercalated PEVA/PEVV at the surface of CHA 
particles. A broad band between 3,150 cm-1 and 3,500 cm-1 
can be attributed to the OH stretching vibrations, which 
belong to various hydroxyl groups present in the sample.
Porous CHA compacts had very porous 3D mac-
rostructure (Figure 1). The pores were cylindrical and 
interconnected, with a diameter of 0.1–1 mm, while most 
of them have a diameter of 0.2–0.3 mm. The average scaf-
fold porosity was 87 ± 8%. Scaffold granules obtained by 
scaffold disintegration were from 300 μm to 1 mm. 
The structure of the inner walls of CHA scaffold granules 
is shown on SEM micrograph (Figure 2). A well-defined 
internal geometry could be observed with the elongated 
grains of a mean diameter 0.5–1.5 μm, and length 1.7–4 μm. 
Investigations of the nano-structure of the scaffold 
walls, by mercury porosimetry, showed the presence of 
nano-pores with diameters of 30–400 nm, with prevailing 
pores in the range of 100–200 nm. 
Indirect cytotoxicity
MTT test
The results of MTT test are presented as the percentage 
of viable L929 fibroblasts in the presence of ALBO-OS 
extracts at different concentrations (obtained after ALBO-
OS degradation in the culture medium after one, 24, and 
72 hours) compared to the controls, which represent a 
pure cell culture of L929 cells without ALBO-OS (Graph 
3). Concerning cell survival relative to the concentration 
of the extract, we noticed the following: for concentration 
of 200 mg/ml (100% extract), the cytotoxic effect was total 
(the number of survived cells was negligible); for concen-
tration of 100 mg/ml (two times diluted extract) survival 
rate was about 15%; for concentration of 50 mg/ml (four 
times diluted 100% extract) survival was 60–70%, and for 
concentrations up to 20 mg/ml, the percentage of survival 
was 80–100%, regardless of the contact time with the cell 
extract. Similar results were obtained for BioOss. BioOss 
extract was obtained after a 72-hour degradation in culture 
Graph 1. XRD pattern of CHA scaffold granules Graph 2. FTIR spectra of CHA scaffold granules 
Figure 1. Enlarged photograph of the CHA compact Figure 2. SEM: Typical appearance of the inner walls of CHA scaffold 





medium and the same concentrations were used as in the 
case of ALBO-OS.
As it is evident from Graph 3, cell survival was only 
slightly dependent on the contact time between the growth 
medium and the material, while it was highly dependent 
on the extract concentration.
In order to define the difference between ALBO-OS 
and BioOss more precisely, only results obtained in the 
presence of ALBO-OS and BioOss extracts obtained after 
72 h were compared (Graph 4). Statistically significant dif-
ference between them was noticed only for concentrations 
of 10 and 20 mg/ml (p < 0.05).
Phase contrast microscopy
The morphology of cells that were in contact with extracts 
of ALBO-OS for 24, 48, or 72 h, were observed by phase 
contrast microscopy (Figures 3a, 3b, and 3c). An increase 
of cytotoxicity with the increase of time the medium and 
ALBO-OS are in contact could be observed (Figure 3a). 
Observing the contact of cells with the ALBO-OS extract 
obtained after one hour of contact with the medium, it can 
be seen that the cell morphology was similar while their 
density was lower than that in the control group (that was 
the case only in contact with the culture medium). When 
the extract obtained after a 24-hour contact was used for 
cell cultivation, cell density was also lower, compared to 
the control, and morphology was changing from elongated 
forms, typical for fibroblasts, to spheroidal form. In the 
case of extract obtained after 72 hours, cell number was 
significantly lower than in the control group and cells were 
spherical in shape.
From Figure 3b it is obvious that the cytotoxicity in-
creased with the increase of contact time of the culture 
medium with ALBO-OS. Observing the cells cultured in 
the ALBO-OS extract obtained after one hour of contact 
with the medium, cell morphology was similar, while their 
density was lower than in the control group. In the case 
of the extracts obtained after 24 and 72 hours, cell density 
was significantly lower than in the control group, and the 
spherical morphology was observed. There was no sig-
nificant difference between the cells that were in contact 
with the extract of ALBO-OS obtained after 24 and 72 h.
The cytotoxicity continued to grow with the increase of 
contact time between the culture medium and ALBO-OS 
(Figure 3c). In contact of the cells with the extract of AL-
BO-OS obtained after one hour, the cell morphology was 
similar, while their density was lower than in the control 
group. When the extract obtained after 24 and 72 hours 
were used, cell density was significantly lower than in the 
control group and the morphology was spherical. A sig-
nificant difference was observed in the density of cells that 
were seeded in the extract of ALBO-OS obtained after 24 
and 72 hours of contact with the culture medium.
It is evident from Graph 5 that the number of viable 
L929 cells slightly decreased when they were exposed to 
the products of ALBO-OS degradation over a period of 
24, 48, and 72 hours, i.e. cytotoxicity slightly increased 
with the increase of contact time between the cells and the 
ALBO-OS extracts. The ratio between the density of sur-
vived cells in three different ALBO-OS extracts (obtained 
after one-, 24-, and 72-hour contact of ALBO-OS and 
medium) and control (expressed as percentage) showed 
mild decrease with the increase of contact time between 
ALBO-OS and medium (Graph 5).
Comparatively observing the presented results, the test 
material ALBO-OS showed quite similar results from the 
standpoint of cytotoxicity on L929 fibroblast culture as the 
Geistlich BioOss (Geistlich Pharma North America Inc., 
Princeton, NJ, USA) gold standard (Graph 3).
Direct Cytotoxicity
Cell proliferation, shown in Graph 6 as the number of cells 
adhered to the surface as a function of time, showed clearly 
that the number of cells grows during the entire period of 
ALBO-OS contact with the cells. The initial cell number 
in the well was 100,000. On the first day of the experiment 
Graph 3. Survival of cell culture of L929 mouse fibroblasts in the pres-
ence of ALBO-OS extract at different concentrations, for the extracts 
obtained after exposure of culture medium to ALBO-OS for one, 24, 
and 72 hours, and in the presence of the extract of BioOss; survival in 
the control group was 100%. Results are given as mean values of three 
independent experiments with five wells in each (n = 15). Standard 
deviations (SD) were between ± 5 (for higher concentrations) and ± 
15 (for lower concentrations).
 Graph 4. MTT viability assay of L929 mouse fibroblasts incubated 
with extracts of ALBO-OS and BioOss (obtained after exposure of cul-
ture medium to ALBO-OS/BioOss for 72 hours). Data are expressed 
as percentage over the control cells, considering the control group 
as 100% (cells without exposure to materials). Results are given as 
mean values of cell viability of three independent experiments with 
five wells in each ± SD (n = 15).
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the number of cells in the presence of ALBO-OS did not 
significantly increase, but from the second day of the ex-
periment the cells were extensively multiplied and their 
number was growing exponentially, so that it was 3.6 × 106 
cells per well on the seventh day. Obviously, ALBO-OS 
did not show cytotoxicity in direct contact with the L929 
fibroblast cell culture because the number of cells grew 
steadily over the entire period of contact. Statistically sig-
nificant difference between ALBO-OS and BioOss was 
noticed after two days (p < 0.001).
Figure 3. Phase contrast microscopy images of mouse fibroblasts L929 treated for: a) 24 h, b) 48 h, and c) 72 h, with extracts obtained after 
contact of culture media with ALBO-OS for one, 24 and 72 hours (magnification 100×)
Graph 5. Percentage of survived cells in ALBO-OS extracts (obtained 
after contact of medium and ALBO-OS for one, 24, and 72 hours) com-
pared with survived cells in control, attained from contrast phase mi-
croscopy images obtained after 24-, 48-, and 72-hour contact with 
cells. For each sample 15 images were analyzed. SDs were between 
± 5 and ± 10.
Graph 6. The number of L929 cells adhered on ALBO-OS and BioOss. 
Data are expressed as mean values ± SD of three independent experi-






High average ALBO-OS scaffold porosity (nearly 87%) and 
its macrostructure, as it is shown in Figure 3a, mainly built 
from cylindrical and interconnected pores with a diameter 
of 200–300 μm, is very suitable for convenient adhesion 
of bone cells. The other very important element for cell 
adhesion and proliferation is very specific nanotopology 
of scaffold pore walls, with properly distributed hills and 
valleys, which enables the attachment of cell filopodia, as 
it is shown in Figure 3b.
Considering the results of MTT assay (Graph 3), it is 
evident that cell survival was highly dependent on the ex-
tract concentration, while it was just slightly dependent 
on the extraction time. The results obtained for ALBO-
OS and BioOss for extraction time of 72 hours were very 
similar, with statistically insignificant difference. Similar 
results, for systems with PLGA alone or a component of 
a composite with CHA, were obtained in other investiga-
tions, showing the cytotoxicity increase with the extract 
concentration, caused mainly by the decrease in pH after 
PLGA degradation to PGA and PLA [20–23].
Phase contrast microscopy showed that the cytotoxicity 
of ALBO-OS slightly increased with the increase of contact 
time between cells and ALBO-OS extracts, while the in-
crease of its cytotoxicity was more pronounced for longer 
extraction time when cell morphology became slightly 
changed (Figure 3 and Graph 5).
LDH assay showed that after the second day of the ex-
periment the cells were already significantly multiplied, 
growing exponentially over the entire period of contact. 
This was also confirmed in previous investigations of 
the same material (ALBO-OS) on dental pulp stem cells, 
where LDH test showed favorable effect of the material on 
the cell proliferation [21]. The comparison of the number 
of cells grown on ALBO-OS and BioOss showed that in 
first two days, when cells were in the adaptation phase, the 
difference was not so significant although the number of 
cells grown on ALBO-OS was about 1.5 times higher. Af-
ter three days, significant difference could be noticed (the 
number of cells on ALBO-OS was about 2.7 times higher 
than on BioOss), while after seven days of cultivation, the 
cell number on ALBO-OS was only 1.6 times higher. The 
difference in cell number on ALBO-OS and BioOss was 
particularly expressed after three days of cultivation. This 
can be assigned to shorter adaptation period of cells to 
ALBO-OS, due to its synthetic origin, while BioOss is of 
natural origin, containing remained collagen fibres, which 
induces corresponding immune response. The results for 
hydroxyapatite-PLGA composite scaffolds obtained in in-
vestigations of other researchers also showed the increase 
of cell number with contact time, but the data are not com-
pletely comparable because the increase of cell number on 
ALBO-OS was significantly faster [24, 25].
CONCLUSION
The paper describes synthesis of hydroxyapatite scaffold 
with surface modified using PLGA thin film, signed as 
ALBO-OS. The phase analysis of ALBO-OS was made by 
XRD and FTIR, while its geometrical structure and ap-
pearance of thin walls of porous body were investigated by 
SEM. The macroscopic structure showed a high degree of 
interconnected pores with a diameter of 0.1–1 mm. Specif-
ic morphology, shown by SEM, indicated that ALBO-OS 
probably has great potential as a synthetic bone substitute.
Biological investigations, using MTT and LDH tests 
and inverse phase microscopy, confirmed that this mate-
rial is not cytotoxic for fibroblast cells L929. The MTT test 
showed similar results for ALBO-OS and Bio-Oss, while 
LDH test of cell viability showed significantly better results 
for ALBO-OS, probably due to its synthetic origin.
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КРАТАК САДРЖАЈ
Увод Порозни биодеградабилни носачи су се показали као 
добри заменици кости јер делују као привремена физичка 
потпора за усмерену регенерацију ткива док се читав носач 
потпуно не разгради и замени новим ткивом.
Циљ рада Циљ овог рада је био да се испита цитотоксич-
ност носача ткива на бази калцијум-хидроксиапатита, висо-
ке порозности и оптималне топологије, названог ALBO-OS.
Методе рада Заменик кости ALBO-OS је синтетисан мето-
дом матрице направљене од полимерне пене. Геометрија 
пора и зидова носача анализиране су помоћу скенирајуће 
електронске микроскопије (СЕМ). Биолошка истраживања 
изведена су испитивањем цитотоксичности ALBO-OS-а на 
мишјим фибробластима L929 помоћу MTT и LDH тестова и 
фазно контрастне микроскопије.
Резултати СЕМ анализа је показала велику и равномерну 
порозност и занимљиву морфологију са биолошког стано-
вишта. Биолошка истраживања показала су да материјал 
није цитотоксичан. Поређењем материјала ALBO-OS и Bio-
Oss, који је, глобално, златни стандард међу заменицима 
кости, добијени су слични резултати на MTT тесту, док су 
резулати LDH теста показали значајно већи број ћелијских 
деоба у контакту са ALBO-OS-ом.
Закључак Дизајн носача са становишта расподеле величи-
не пора и топологије је веома погодан за адхезију и насеља-
вање ћелија, због чега има велики потенцијал као заменик 
кости. Резултати биолошких тестова су показали да ALBO-OS 
није цитотоксичан за L929 фибробласте. У поређењу са ма-
теријалом Bio-Oss, добијени су слични или бољи резултати.
Кључне речи: хидроксиапатит; цитотоксичност; MTT; LDH
Испитивање цитотоксичности носача на бази хидроксиапатита с унапређеним 
структурним дизајном
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